Skip to main content

Bietti Crystalline Corneoretinal Dystrophy

OMIM ID:

autosomal recessive

Bietti Crystalline Corneoretinal Dystrophy

Alternate Names

Bietti tapetoretinal degeneration with marginal corneal dystrophy
BCD

Defective Genes

CYP4V2

Clinical Characteristics

Ocular Features

The retina contains refractile glistening intraretinal crystals at all levels and choroidal vessels are said to be sclerosed.  The RPE atrophies and often forms pigment clumps.  The yellow-white crystals may be seen in the peripheral cornea and in the limbus.  Symptoms of night blindness and early vision loss begin about the third decade.  Night blindness is progressive as is the narrowing of the visual fields but this is highly variable between patients.  The visual field may show paracentral scotomas at some stage.  Central acuity can be normal until late in the disease when it becomes markedly impaired. Legal blindness can occur by the 5th decade of life. 

The ERG may show lack of rod and cone responses late in the disease and color vision may be lost.  However, the ffERG and mfERGs show decreases in amplitude of scotopic and photopic responses in all patients, even younger ones.  The EOG becomes abnormal in late stages.  The degree of involvement may be asymmetrical.  Complex lipid inclusions can be seen histologically in choroidal, conjunctival and skin fibroblasts, as well as in keratocytes and lymphocytes.

Crystalline deposits have been detected mostly in the proximal portions of RPE cells adjacent to degenerated retinal  areas.  Most common are circular hyperrefractive structures in the outer nuclear layer adjacent to areas of degeneration.  Some patients have cystoid macular edema. Others in late stages have fundus changes that resemble choroideremia.

Systemic Features

No other organ disease has been reported.

Genetics

Inheritance

This is an autosomal recessive disorder caused by mutations in the CYP4V2 gene (4q35.1) involved in fatty acid metabolism.

A homozygous CYP4V2 mutation has also been reported in patients with a choroideremia-like clinical phenotype.

Pedigree

Autosomal recessive

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent.  Carriers with only one mutation, such as the parents, do not have clinical disease.  Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Image
Sample pedigree of autosomal recessive inheritance

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Treatment & Management

No treatment beyond low vision aids is available.

Publications

Displaying 1 - 7 of 7

A novel homozygous CYP4V2 variant (p.S121Y) associated with a choroideremia-like phenotype

PubMedID: 27348340

Bietti Crystalline Corneoretinal Dystrophy Is Caused by Mutations in the Novel Gene CYP4V2

PubMedID: 15042513

Bietti Crystalline Dystrophy

PubMedID: 22497028

Cystoid Macular Edema in Bietti’s Crystalline Retinopathy

PubMedID: 24949209

Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization

PubMedID: 27028354

Electrophysiological findings in Bietti’s crystalline dystrophy

PubMedID: 21488952

Outer retinal circular structures in patients with Bietti crystalline retinopathy

PubMedID: 21803923